PuraPharm (HKSE:01498) Other Long-Term Liabilities : HK$16.9 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is PuraPharm Other Long-Term Liabilities?

PuraPharm's other long-term liabilities for the quarter that ended in Dec. 2023 was HK$16.9 Mil.

PuraPharm's quarterly other long-term liabilities declined from Dec. 2022 (HK$18.3 Mil) to Jun. 2023 (HK$16.4 Mil) but then increased from Jun. 2023 (HK$16.4 Mil) to Dec. 2023 (HK$16.9 Mil).

PuraPharm's annual other long-term liabilities declined from Dec. 2021 (HK$27.9 Mil) to Dec. 2022 (HK$18.3 Mil) and declined from Dec. 2022 (HK$18.3 Mil) to Dec. 2023 (HK$16.9 Mil).

PuraPharm Other Long-Term Liabilities Historical Data

The historical data trend for PuraPharm's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuraPharm Other Long-Term Liabilities Chart

PuraPharm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

PuraPharm Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

PuraPharm Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

PuraPharm Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of PuraPharm's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PuraPharm (HKSE:01498) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PuraPharm Corporation Ltd (HKSE:01498) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

Wireless Centre, Phase One, Unit 201-207, 2nd Floor, Hong Kong Science Park, Tai Po, New Territories, Hong Kong, HKG

Website

https://www.purapharm.com

PuraPharm Corporation Ltd is a Hong Kong-based Chinese medicine Company. It is engaged in the research and development, production, marketing and sale of concentrated Chinese medicine granules (CCMG) products marketed under the brand Nong's. In addition, the organization is engaged in rendering Chinese medical diagnostic services. The operating segments of the group are China CCMG, Hong Kong CCMG, Chinese healthcare products, Plantation and Clinics. It generates maximum revenue from the China CCMG segment mainly engages in the production and sale of CCMG products in China. The group derives revenue from the customers located in Hong Kong, Mainland China and Other countries.

PuraPharm (HKSE:01498) Headlines

No Headlines